Gene Therapy Drug Articles & Analysis
9 news found
They play an essential role in intercellular communication and hold high potential as drug delivery systems due to their natural ability to carry and deliver substances within the body. BOC Sciences' inclusion of exosome drug delivery technologies aims to leverage this potential and enhance their applications in RNA therapeutics. ...
In recent years, CRISPR technology has significantly promoted the innovation of gene therapy for blood diseases, tumors, genetic diseases, and other diseases, which has become a powerful tool in the field of scientific research. ...
“This clinical data validates the significant potential of our patented platform to deliver therapeutics as varied as gene therapy, virus-like drug conjugates, and small molecules directly to the back of the eye in an office-based, non-surgical procedure. ...
Compared with traditional drug therapy, gene therapy is to fundamentally control the disease, so it has a very good development prospect, and has received more and more attention and investment from the pharmaceutical industry worldwide. Gene therapy drugs are in clinical trials ...
At CPhI Worldwide 2021, Thermo Fisher Scientific will showcase its newest capabilities across its global pharma services network which help pharmaceutical and emerging biotech companies accelerate time to market in a wide range of modalities and platforms including cell and gene therapies, drug products and biologics. CPhI 2021 begins with a ...
This week, Thermo Fisher Scientific will highlight its investments and innovations over the past 12 months across its global pharma services network, which have been focused on areas of accelerated demand including cell and gene therapy, drug product development, biologics manufacturing and clinical supply chain services. ...
Earlier this year, the company announced plans to invest in new capabilities and capacity for biologics, cell and gene therapies and drug product development and commercialization. For example, to support demand for gene therapies, Thermo Fisher will be doubling its viral vector manufacturing capacity with a new ...
Celixir publishes positive study results for potential cancer gene therapies showing cancer cell reduction in colon and breast cancer cell lines Promising cancer gene therapy programme using small interfering RNA (siRNA) Data from in vitro study published in PLOS journal Stratford-upon-Avon, UK, 13 May 2019 – ...
Vybion (NY) conducted a webinar, sponsored by the Huntington's Disease Society of America (HSDA), for patients and caregivers on a new Gene Therapy drug called INT41. The company CEO described this new drug class called Intrabodies and how INT41 works in Huntington's Disease along with clinical development plans. ...
ByVybion